from Breakingviews:

Shire’s merger with Baxalta looks a little peaky

January 11, 2016

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

from Breakingviews:

Healthcare M&A will wear down in 2016

January 4, 2016

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

from Breakingviews:

Valeant’s latest fix reinforces its challenges

December 28, 2015

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

from Breakingviews:

Sanofi and Boehringer scratch each others’ backs

December 15, 2015

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

from Breakingviews:

Cox: Two signs of M&A bacchanal’s last hurrah

By Rob Cox
December 1, 2015

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

from Breakingviews:

Pfizer’s war chest stealthily rebuilt by Allergan

November 25, 2015

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

from Breakingviews:

Delay in Pfizer split is material adverse event

November 24, 2015

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

from Breakingviews:

Pfizer-Allergan to throw down tax-reform gauntlet

November 23, 2015

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

from Breakingviews:

Heads won’t roll at Mylan despite blunders

November 13, 2015

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

from Breakingviews:

Valeant CEO gets called on $100 mln excess

November 6, 2015

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.